Athelas develops technology to monitor chronically ill patients in their homes.
Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 31, 2022 | Series Unknown | $59.43M | 7 | Tribe Capital | — | Detail |
Aug 10, 2021 | Series B | $72M | 2 | General Catalyst | — | Detail |
Feb 1, 2019 | Series A | $15M | 2 | Georges Harik | — | Detail |
Aug 28, 2017 | Seed | $3.70M | 11 | Sequoia Capital | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 11, 2022
Klarna
|
Series Unknown | $800M | E-Commerce | — |
Apr 8, 2019
Klarna
|
Private Equity(PE) | $93M | E-Commerce | — |
Mar 14, 2014
Klarna
|
Series Unknown | €90M | E-Commerce | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Tribe Capital | Yes | Series Unknown |
General Catalyst | Yes | Series B |
Georges Harik | Yes | Series A |
Sequoia Capital | — | Series Unknown |
Fifty Years | — | Series Unknown |
Greenoaks | — | Series Unknown |
Human Capital | — | Series Unknown |
Initialized Capital | — | Series Unknown |
Y Combinator | — | Series Unknown |
CJ Reim | — | Seed |